CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED

Highlights China Resources Pharmaceutical Group Limited

Equities

3320

HK0000311099

Market Closed - Hong Kong S.E. Other stock markets 04:08:24 2024-07-08 am EDT			5-day change	1st Jan Change
5.58 ^HKD	-2.96%		-2.96%	+8.77%

Jun. 21	China Resources Pharmaceutical Unit Renews Energy Purchase Contract with China Resources Gas Subsidiary	MT
Jun. 11	China Resources Pharmaceutical to Cut Stake in Subsidiary	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China Resources Pharmaceutical Unit Renews Energy Purchase Contract with China Resources Gas Subsidiary	Jun. 21	MT
China Resources Pharmaceutical to Cut Stake in Subsidiary	Jun. 11	MT
China Resources Pharmaceutical Group Limited Approves Final Dividend for the Year Ended 31 December 2023	May. 30	CI
China Resources Sanjiu, China Resources Power to Continue Cooperating on New Energy Projects	May. 16	MT
China Resources Pharma Unit Issues 3 Billion Yuan Bonds	Apr. 18	MT
China Resources Dong-E-E-Jiao Company Limited Provides Earnings Guidance for the Three Months Ended 31 March 2024	Apr. 11	CI
China Resources Pharmaceutical Posts Gains in Full Year 2023 Profit	Mar. 26	MT
China Resources Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 19 July 2024	Mar. 26	CI
China Resources Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
CR Boya Bio-Pharmaceutical's 2023 Profit Falls on Lower Revenue	Mar. 14	MT
CR Sanjiu Expects Increase in 2023 Profit	Jan. 24	MT
China Resources Pharmaceutical Unit Completes Capital Increase; Shares Fall 3%	Jan. 08	MT
China Resources Pharmaceutical Unit Enters Share Subscription Deals to Boost Capital	Dec. 28	MT
China Resources Pharma Unit Boosts Stake in Jiangzhong Pharma Parent	Dec. 27	MT
Dong-E-E-Jiao's Nine-Moth Profit Rises on Higher Revenue	23-10-31	MT
CR Boya Bio-Pharmaceutical's January-September Profit Increases	23-10-25	MT
Dong-E-E-Jiao Expects January-September Attributable Profit to Rise Up to 60%	23-10-10	MT
China Resources Pharma's Profit Marginally Rises in H1	23-08-31	MT
China Resources Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-31	CI
CR Sanjiu Medical & Pharmaceutical's H1 Attributable Profit Rises 31%	23-08-29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights China Resources Pharmaceutical Group Limited

Equities

3320

HK0000311099

Highlights

Filters